Delivery Order SPE2DR25D2010-SPE2DR26F4YUT
- Not listed
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product. The contract, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product, with a completion date of August 21, 2025. This competitive award (no set-aside used) was issued under a firm fixed-price structure and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.26 to AmerisourceBergen Drug Corp for ProQuad vials on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $5,062.32 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 4, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and represents a routine pharmaceutical procurement from the DLA Medical Supply Chain. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $2,686.44 to AmerisourceBergen Drug Corp for ProQuad vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement under the company's existing DLA contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $33,086.60 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of October 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $10,961.60 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of October 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4YUTDelivery Order
The Defense Logistics Agency awarded a $6,538.48 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of November 25, 2025. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and is performing the work at its corporate office location in Conshohocken. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. ProQuad, a combination vaccine, represents one of the specialized medical commodities available through this contract vehicle, which also encompasses brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 11/3/25 |